Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Armuzzi

Showing results (91-100 of 320) with videos related to

Pageof 32
Sort By:
Autoimmunity Reviews|April 15, 2014
Italian Expert Panel on the management of patients with coexisting spondyloarthritis and inflammatory bowel diseaseIgnazio Olivieri, Fabrizio Cantini, Fabiana Castiglione, et al.
Professioni Infermieristiche|December 28, 2020
The awareness of the IBD nurse position among patients from an Italian tertiary IBD centreDaniele Napolitano, Piergiorgio Martella, Elisa Schiavoni, et al.
Frontiers in Medicine|November 28, 2022
Technological advances in inflammatory bowel disease endoscopy and histologyLudovico Alfarone, Tommaso Lorenzo Parigi, Roberto Gabbiadini, et al.
Expert Opinion on Biological Therapy|June 14, 2024
Management of proctitis in ulcerative colitis and the place of biological therapiesDiletta De Deo, Arianna Dal Buono, Roberto Gabbiadini, et al.
BMC Gastroenterology|January 23, 2020
The association between disease activity and patient-reported outcomes in patients with moderate-to-severe ulcerative colitis in the United States and EuropeAlessandro Armuzzi, Miriam Tarallo, James Lucas, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|August 23, 2017
Indicators of suboptimal tumor necrosis factor antagonist therapy in inflammatory bowel diseaseJames O Lindsay, Alessandro Armuzzi, Javier P Gisbert, et al.
Inflammatory Bowel Diseases|May 13, 2025
Developing IBD Outcome Effect Size Thresholds to Inform Research, Guidelines, and Clinical DecisionsMorris Gordon, Nader Shaban, Vasiliki Sinopoulou, et al.
Therapeutic Advances in Gastroenterology|May 15, 2026
Clinical characteristics and treatment pathways of ulcerative colitis patients with isolated proctitis in Europe and the United StatesAlessandro Armuzzi, Silvio Danese, Manuel Barreiro-de Acosta, et al.
Digestion|September 14, 2017
Effectiveness of Mesalazine, Thiopurines and Tumour Necrosis Factor Antagonists in Preventing Post-Operative Crohn's Disease Recurrence in a Real-Life SettingMariangela Allocca, Rosario Landi, Stefanos Bonovas, et al.
Crohn'S & Colitis 360|November 13, 2025
Rate of Participation in a Second Randomized Clinical Trial and Factors Associated with the Likelihood of Participation among IBD Patients who already Experienced a Randomized Clinical TrialRoberto Gabbiadini, Demis Pitoni, Peter Bertoli, et al.
Pageof 32

Showing results (91-100 of 320) with videos related to

Sort By:
Pageof 32
Autoimmunity Reviews|April 15, 2014
Italian Expert Panel on the management of patients with coexisting spondyloarthritis and inflammatory bowel diseaseIgnazio Olivieri, Fabrizio Cantini, Fabiana Castiglione, et al.
Professioni Infermieristiche|December 28, 2020
The awareness of the IBD nurse position among patients from an Italian tertiary IBD centreDaniele Napolitano, Piergiorgio Martella, Elisa Schiavoni, et al.
Frontiers in Medicine|November 28, 2022
Technological advances in inflammatory bowel disease endoscopy and histologyLudovico Alfarone, Tommaso Lorenzo Parigi, Roberto Gabbiadini, et al.
Expert Opinion on Biological Therapy|June 14, 2024
Management of proctitis in ulcerative colitis and the place of biological therapiesDiletta De Deo, Arianna Dal Buono, Roberto Gabbiadini, et al.
BMC Gastroenterology|January 23, 2020
The association between disease activity and patient-reported outcomes in patients with moderate-to-severe ulcerative colitis in the United States and EuropeAlessandro Armuzzi, Miriam Tarallo, James Lucas, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|August 23, 2017
Indicators of suboptimal tumor necrosis factor antagonist therapy in inflammatory bowel diseaseJames O Lindsay, Alessandro Armuzzi, Javier P Gisbert, et al.
Inflammatory Bowel Diseases|May 13, 2025
Developing IBD Outcome Effect Size Thresholds to Inform Research, Guidelines, and Clinical DecisionsMorris Gordon, Nader Shaban, Vasiliki Sinopoulou, et al.
Therapeutic Advances in Gastroenterology|May 15, 2026
Clinical characteristics and treatment pathways of ulcerative colitis patients with isolated proctitis in Europe and the United StatesAlessandro Armuzzi, Silvio Danese, Manuel Barreiro-de Acosta, et al.
Digestion|September 14, 2017
Effectiveness of Mesalazine, Thiopurines and Tumour Necrosis Factor Antagonists in Preventing Post-Operative Crohn's Disease Recurrence in a Real-Life SettingMariangela Allocca, Rosario Landi, Stefanos Bonovas, et al.
Crohn'S & Colitis 360|November 13, 2025
Rate of Participation in a Second Randomized Clinical Trial and Factors Associated with the Likelihood of Participation among IBD Patients who already Experienced a Randomized Clinical TrialRoberto Gabbiadini, Demis Pitoni, Peter Bertoli, et al.
Pageof 32